NCT00313781 · Interventional trial
Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)
Overall registry status Completed
Phase 2
Conditions Prostatic Neoplasms
Delaware Valley sites
- Pfizer Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory